Prescribers have been slow to adapt Biosimilars: 78% familiar with term, but only 17% likely to prescribe #PwCSpecialtyWebinar
Prescribers have been slow to adapt Biosimilars: 78% familiar with term, but only 17% likely to prescribe #PwCSpecialtyWebinar